AU7942087A - Sustained release formulations - Google Patents

Sustained release formulations

Info

Publication number
AU7942087A
AU7942087A AU79420/87A AU7942087A AU7942087A AU 7942087 A AU7942087 A AU 7942087A AU 79420/87 A AU79420/87 A AU 79420/87A AU 7942087 A AU7942087 A AU 7942087A AU 7942087 A AU7942087 A AU 7942087A
Authority
AU
Australia
Prior art keywords
sustained release
release formulations
formulations
sustained
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79420/87A
Other languages
English (en)
Inventor
Henry C. Gan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU7942087A publication Critical patent/AU7942087A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU79420/87A 1986-10-09 1987-10-07 Sustained release formulations Abandoned AU7942087A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions
GB8624213 1986-10-09

Publications (1)

Publication Number Publication Date
AU7942087A true AU7942087A (en) 1988-04-14

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79420/87A Abandoned AU7942087A (en) 1986-10-09 1987-10-07 Sustained release formulations

Country Status (24)

Country Link
JP (1) JPS63101334A (hu)
KR (1) KR880004801A (hu)
AU (1) AU7942087A (hu)
BE (1) BE1000732A5 (hu)
CA (1) CA1332809C (hu)
CH (1) CH675831A5 (hu)
DE (1) DE3733540A1 (hu)
DK (1) DK527487A (hu)
ES (1) ES2014518A6 (hu)
FI (1) FI874414A (hu)
FR (1) FR2604902B1 (hu)
GB (2) GB8624213D0 (hu)
GR (1) GR871550B (hu)
HU (1) HU201875B (hu)
IL (1) IL84104A0 (hu)
IT (1) IT1221493B (hu)
LU (1) LU87009A1 (hu)
NL (1) NL8702294A (hu)
NO (1) NO874200L (hu)
NZ (1) NZ222083A (hu)
PH (1) PH24227A (hu)
PT (1) PT85880B (hu)
SE (1) SE8703889L (hu)
ZA (1) ZA877617B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
KR100660594B1 (ko) * 1999-03-31 2006-12-22 얀센 파마슈티카 엔.브이. 방출 조절형 제제중의 프리젤라틴화 전분
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
EP1803447B1 (en) * 2004-09-09 2009-07-22 Psicofarma, S.A. De C.V. Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제

Also Published As

Publication number Publication date
HUT52958A (en) 1990-09-28
PT85880B (pt) 1990-07-31
FR2604902B1 (fr) 1991-04-26
FI874414A0 (fi) 1987-10-07
CA1332809C (en) 1994-11-01
PT85880A (en) 1987-11-01
SE8703889L (sv) 1988-04-10
LU87009A1 (fr) 1988-05-03
ZA877617B (en) 1989-05-30
HU201875B (en) 1991-01-28
GB2195893B (en) 1991-05-08
ES2014518A6 (es) 1990-07-16
DK527487D0 (da) 1987-10-08
PH24227A (en) 1990-05-04
FI874414A (fi) 1988-04-10
GB8723515D0 (en) 1987-11-11
DK527487A (da) 1988-04-10
KR880004801A (ko) 1988-06-27
NL8702294A (nl) 1988-05-02
FR2604902A1 (fr) 1988-04-15
GB8624213D0 (en) 1986-11-12
GB2195893A (en) 1988-04-20
NZ222083A (en) 1991-05-28
CH675831A5 (hu) 1990-11-15
IT8748469A0 (it) 1987-10-08
IL84104A0 (en) 1988-03-31
NO874200D0 (no) 1987-10-07
SE8703889D0 (sv) 1987-10-08
DE3733540A1 (de) 1988-04-14
GR871550B (en) 1988-02-15
JPS63101334A (ja) 1988-05-06
BE1000732A5 (fr) 1989-03-21
IT1221493B (it) 1990-07-06
NO874200L (no) 1988-04-11

Similar Documents

Publication Publication Date Title
AU2164088A (en) Controlled release formulations
AU589866B2 (en) Sustained release capsule
AU6394786A (en) Sustained release compositions
AU6893287A (en) Sustained release pharmaceutical preparation
AU1828988A (en) Controlled release formulation
AU8131191A (en) Sustained release formulations
AU7663687A (en) Soil release composition
AU8298287A (en) Transdermal contraceptive formulations
AU2707788A (en) Sustained release pharmaceutical composition
AU639947B2 (en) Sustained release elements
AU1219388A (en) Sustained release matrix formulations
AU7756487A (en) Pharmaceutical formulations
AU1174388A (en) Sustained release dosage forms
AU581274B2 (en) Theophylline sustained release formulation
AU8130391A (en) Solid formulations
AU6792187A (en) Polymerisable compositions
AU6111390A (en) Pesticidal formulations
AU7942087A (en) Sustained release formulations
AU556090B2 (en) Controlled release formulations
AU1366188A (en) Shampoo formulations
AU2431388A (en) Somototropin formulations
AU627847B2 (en) Pesticidal formulations
AU6913287A (en) Transdermal formulations
AU7779987A (en) Multi-purpose formulations
AU589254C (en) Slow release formulations